Advertisement

Pulmonary Toxicity Associated with Radiation Treatment for Breast Cancer

  • Arti ParekhEmail author
Chapter

Abstract

Clinically apparent pulmonary toxicities are quite rare after radiation for breast cancer, and thus data regarding pulmonary toxicity from breast radiation is relatively limited and heterogeneous. The pulmonary toxicity profile includes the acute/subacute toxicity radiation pneumonitis (RP), as well as late toxicities of pulmonary fibrosis and secondary lung cancers. Here we review available data regarding the range of pulmonary toxicities observed after adjuvant breast radiation, as well as techniques for minimization.

Keywords

Pulmonary fibrosis Radiation pneumonitis Breast radiation Toxicity 

References

  1. 1.
    Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat. 2001;68(3):199–210.CrossRefGoogle Scholar
  2. 2.
    Lind PA, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999;43(3):489–96.CrossRefGoogle Scholar
  3. 3.
    Gokula K, Earnest A, Wong LC. Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas. Radiat Oncol. 2013;8:268.CrossRefGoogle Scholar
  4. 4.
    Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21(2):355–60.CrossRefGoogle Scholar
  5. 5.
    Whelan TJ, Olivotto IA, Levine MN. Regional nodal irradiation in early-stage breast Cancer. N Engl J Med. 2015;373(19):1878–9.PubMedGoogle Scholar
  6. 6.
    Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, et al. Technical factors associated with radiation pneumonitis after local +/− regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):137–43.CrossRefGoogle Scholar
  7. 7.
    Carter DL, Marks LB, Bentel GC. Impact of setup variability on incidental lung irradiation during tangential breast treatment. Int J Radiat Oncol Biol Phys. 1997;38(1):109–15.CrossRefGoogle Scholar
  8. 8.
    Bornstein BA, Cheng CW, Rhodes LM, Rashid H, Stomper PC, Siddon RL, et al. Can simulation measurements be used to predict the irradiated lung volume in the tangential fields in patients treated for breast cancer? Int J Radiat Oncol Biol Phys. 1990;18(1):181–7.CrossRefGoogle Scholar
  9. 9.
    Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8(3):145–52.CrossRefGoogle Scholar
  10. 10.
    Pramana ABL, Cox H, Saba A, Lim J, Graham P. Pulmonary fibrosis following breast adjuvant radiation therapy: the modifying effects of endocrine and chemotherapy. IJROBP. 2015;93(3):S106.Google Scholar
  11. 11.
    Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.CrossRefGoogle Scholar
  12. 12.
    Brownlee Z, Garg R, Listo M, Zavitsanos P, Wazer DE, Huber KE. Late complications of radiation therapy for breast cancer: evolution in techniques and risk over time. Gland Surg. 2018;7(4):371–8.CrossRefGoogle Scholar
  13. 13.
    Poortmans PM, Struikmans H, Bartelink H. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(19):1879–80.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Allegheny General HospitalPittsburghUSA

Personalised recommendations